Entrepreneurship in Biotech and Healthtech

You are invited to the HBS Healthcare Alumni Association's Healthtech and Biotech Meetup event on November 14th at 6pm in San Francisco.

Join our discussion with our panelists, Andy Coravos (MBA 2017) from HumanFirst, Philip Jeng (MBA 2019) from Think Bioscience, and Jenny Herbach (MBA 2013), from Adventris Pharmaceuticals, and our regional director, Antonio Henriques (MBA 2017), from Exelixis. Our panelists will be sharing their founding journeys and takeaways from founder-led startups in biotech and healthtech. The panel discussion will be followed by a happy hour with fellow HBS alumni, members of the broader Harvard community, and industry professionals.

Date: Tuesday, November 14th

6:00 pm – Reception
6:30 pm - Fireside Chat
(Reception will continue after the discussion for more socializing and networking.)

Pillsbury Winthrop Shaw Pittman LLP
4 Embarcadero Center
San Francisco

Harvard Club of San Francisco Members - $8

HBSHAA members can register for free HERE

Not a member? Register here for membership!
All new grads are eligible for a one-year-free membership at the Harvard Club of San Francisco. Please register online.
Click here to register

Event Registration (Harvard Alumni):
Please sign in with your HarvardKey otherwise a duplicate record will be created and you will not be able to log-in.
No HarvardKey? Please retrieve your HarvardKey here. If you need help, email ithelp@harvard.edu or call 617-495-7777

HCSF Guidelines for attending in-person events
If you are showing COVID-19 or Flu symptoms, please stay home. This is critical to the health and safety of our staff and communities.
Andrea Coravos, MBA 2017, Founder, Human First
Jenny Herbach, MBA 2013, CEO & Co-Founder, Adventris Pharmaceuticals
Philip Jeng, MBA 2019, Co-Founder, Think Bioscience
Moderator, Antonio Henriques, MBA 2017, Regional Director, HBSHAA and Business Development, Exelixis


Andy Coravos is the CEO/Co-Founder of HumanFirst, a cloud-based technology company for the life sciences. The Atlas platform by HumanFirst provides comprehensive insights on precision measures and multi-modal technologies, including AI-powered biomarkers and COAs, to accelerate drug development.‍ To date, HumanFirst has curated more than 15,000 digital measures and biomarkers captured from more than 3,100 digital health technologies deployed across 1,700 clinical trials, all backed by more than 9,000 pieces of evidence. In addition to her work with HumanFirst, Coravos is also a research collaborator at the Harvard-MIT Center for Regulatory Sciences. Formerly, she served as an Entrepreneur in Residence at the FDA working in the Digital Health Unit (DHU), focusing on the Pre-Cert program and policies around software-as-a-medical-device and AI/ML. Coravos has also worked as a software engineer at a leading digital therapeutic company and as a healthcare consultant at both KKR, a private equity firm, and McKinsey & Company, a management consulting firm.

Philip Jeng is the COO & co-founder of Think Bioscience, a biotech startup focused on developing novel small molecules for historically challenging targets. Prior to Think Bioscience, he worked in Corporate Development at Neurophth Therapeutics and held an entrepreneur-in-residence role as a Harvard Blavatnik Fellow. At ZS Associates, he advised clients on strategy, market access, and market research projects. He began his career in the Process Development Rotational Program (PDRP) at Genentech. Philip holds a BS in Bioengineering from UC Berkeley and an MBA from Harvard.

Jenny Herbach (Bio coming soon!)